Garvan Institute of Medical Research
The Garvan Institute of Medical Research & St Vincent’s & Mater Health Sydney was awarded a $2.5 million grant to establish a new world-class comprehensive cancer centre – the Garvan St Vincent’s Campus Cancer Centre – on the St Vincent’s research precinct in Sydney.
The centre, called the Kinghorn Cancer Centre, supports multidisciplinary teams for the holistic and ultimately improved care of patients throughout their cancer treatment and fosters the highest level of collaboration between researchers and clinical investigators.
The Garvan group is seen as one of the best basic breast cancer biology research groups in Australia. It has a strong commitment to translational research in breast cancer and other cancers.
Senior researchers: Prof. Robert L Sutherland, Prof. Allan D Spigelman, A/Prof. Andrew V. Biankin
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialed for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.